Transmissibility of 1918 pandemic influenza
暂无分享,去创建一个
[1] W. R. Hand. Johns Hopkins Hospital Reports , 1894, Glasgow Medical Journal.
[2] L. L. Stanley. Influenza at San Quentin Prison, California , 1919 .
[3] W. H. Frost. Statistics of Influenza Morbidity: With Special Reference to Certain Factors in Case Incidence and Case Fatality , 1920 .
[5] E. O. Jordan,et al. Epidemic Influenza. A Survey. , 1927 .
[6] S. D. Collins,et al. Mortality from Influenza and Pneumonia in 50 Large Cities of the United States, 1910-1929. , 1930 .
[7] D. W. Henderson,et al. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey , 1956, Journal of Hygiene.
[8] J. M. Ross. The pathogenesis of anthrax following the administration of spores by the respiratory route , 1957 .
[9] S. Shapiro. THE EPIDEMIOLOGY OF INFLUENZA. , 1965, Eye, ear, nose & throat monthly.
[10] C C Spicer,et al. Epidemic influenza in Greater London , 1984, Journal of Hygiene.
[11] L. A. Rvachev,et al. A mathematical model for the global spread of influenza , 1985 .
[12] R. May,et al. Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.
[13] K. D. Patterson,et al. The geography and mortality of the 1918 influenza pandemic. , 1991, Bulletin of the history of medicine.
[14] J. Ezzell,et al. Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.
[15] P. Kaye. Infectious diseases of humans: Dynamics and control , 1993 .
[16] A Watson,et al. Information on which to base assessments of risk from environments contaminated with anthrax spores , 1994, Epidemiology and Infection.
[17] M. Hugh-jones,et al. The Sverdlovsk anthrax outbreak of 1979. , 1994, Science.
[18] M. Meltzer,et al. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? , 1997, Emerging infectious diseases.
[19] L. Simonsen,et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. , 1998, The Journal of infectious diseases.
[20] Philip K. Russell,et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 1999, JAMA.
[21] A. Friedlander. Anthrax: clinical features, pathogenesis, and potential biological warfare threat. , 2000, Current clinical topics in infectious diseases.
[22] Fried Am. Anthrax: clinical features, pathogenesis, and potential biological warfare threat. , 2000 .
[23] C. P. Quinn,et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. , 2001, Emerging infectious diseases.
[24] Lee L. Zwanziger,et al. The Anthrax Vaccine. Is It Safe? Does It Work? , 2002 .
[25] R. Brookmeyer,et al. Prevention of Inhalational Anthrax in the U.S. Outbreak , 2002, Science.
[26] Jerome Hauer,et al. Anthrax as a biological weapon, 2002: updated recommendations for management. , 2002, JAMA.
[27] Charles N Haas,et al. On the Risk of Mortality to Primates Exposed to Anthrax Spores , 2002, Risk analysis : an official publication of the Society for Risk Analysis.
[28] David L. Craft,et al. Emergency response to a smallpox attack: The case for mass vaccination , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Nizam,et al. Containing Bioterrorist Smallpox , 2002, Science.
[30] Elizabeth R. Zell,et al. Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence , 2002, Emerging infectious diseases.
[31] J. Gog,et al. Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Fraser,et al. Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions , 2003, Science.
[33] R. Webster,et al. Are We Ready for Pandemic Influenza? , 2003, Science.
[34] J. Robins,et al. Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.
[35] I. Longini,et al. The critical vaccination fraction for heterogeneous epidemic models. , 2003, Mathematical biosciences.
[36] N. Ferguson,et al. Planning for smallpox outbreaks , 2003, Nature.
[37] Sally C Morton,et al. A model for a smallpox-vaccination policy. , 2003, The New England journal of medicine.
[38] R. Brookmeyer,et al. Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Wallinga,et al. Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures , 2004, American journal of epidemiology.
[40] C. Fraser,et al. Factors that make an infectious disease outbreak controllable. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Nizam,et al. Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.